Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATHE | AZN | AMGN | GILD | BMY |
| Company | Alterity Therapeutics Ltd ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 4.39 | 178.32 | 352.00 | 125.22 | 56.41 |
| High | 4.70 | 179.12 | 353.66 | 128.18 | 56.62 |
| Low | 4.39 | 176.64 | 345.87 | 124.14 | 55.45 |
| Latest | 4.65 | 178.71 | 347.84 | 127.23 | 55.92 |
| Change | +0.24 | +1.44 | -2.69 | +2.93 | -0.32 |
| % Change | +5.44% | +0.81% | -0.77% | +2.36% | -0.57% |
| Volume | 39,600 | 1,895,800 | 3,516,700 | 9,381,800 | 11,945,700 |
| 20-Day Average Volume | 7,054 | 2,001,475 | 2,806,830 | 8,213,255 | 11,571,340 |
| Previous Close | 4.41 | 177.27 | 350.53 | 124.30 | 56.24 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 174.43 | 182.74 | 340.54 | 129.41 | 56.87 |
| 20-Day Raw Stochastic | 0.21% | 24.32% | 71.68% | 36.94% | 28.43% |
| 20-Day Relative Strength | 16.92 | 43.79 | 53.52 | 44.61 | 46.07 |
| Weighted Alpha | -24.00 | +18.77 | +18.32 | +11.31 | +17.16 |
| Today's Opinion | 56% Sell | 56% Sell | 40% Buy | 56% Sell | 24% Sell |
| Previous Opinion | 56% Sell | 56% Sell | 24% Buy | 56% Sell | 8% Sell |
| Last Month's Opinion | 48% Buy | 24% Sell | 24% Sell | 16% Sell | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -97.83% since 06/09/26 | -2.57% since 06/09/26 | +0.95% since 06/09/26 | +1.38% since 06/09/26 | -0.99% since 06/09/26 |
| Low | 4.14 on 06/12/26 | 176.55 on 06/15/26 | 337.49 on 06/10/26 | 121.39 on 06/10/26 | 55.44 on 06/16/26 |
| High | 213.00 on 06/11/26 | 183.67 on 06/11/26 | 358.46 on 06/11/26 | 128.18 on 06/16/26 | 57.60 on 06/12/26 |
| 1-Month | |||||
| %Chg | -97.69% since 05/15/26 | -1.58% since 05/15/26 | +6.60% since 05/15/26 | -1.81% since 05/15/26 | -1.89% since 05/15/26 |
| Low | 4.14 on 06/12/26 | 174.60 on 06/03/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 54.20 on 06/02/26 |
| High | 252.00 on 06/09/26 | 191.50 on 05/21/26 | 358.46 on 06/11/26 | 137.20 on 05/29/26 | 60.25 on 05/22/26 |
| 3-Month | |||||
| %Chg | -97.42% since 03/16/26 | -6.93% since 03/16/26 | -5.03% since 03/16/26 | -12.38% since 03/16/26 | -6.35% since 03/16/26 |
| Low | 4.14 on 06/12/26 | 174.60 on 06/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 54.20 on 06/02/26 |
| High | 262.50 on 04/20/26 | 207.30 on 04/10/26 | 368.78 on 03/17/26 | 146.71 on 03/17/26 | 62.22 on 04/01/26 |
| 6-Month | |||||
| %Chg | -96.97% since 12/16/25 | -2.18% since 12/16/25 | +6.46% since 12/16/25 | +7.11% since 12/16/25 | +3.12% since 12/16/25 |
| Low | 4.14 on 06/12/26 | 174.60 on 06/03/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 262.50 on 04/20/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 39,104 | 274,929,472 | 189,183,840 | 154,327,152 | 114,846,080 |
| Shares Outstanding, K | 8,867 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -7,870,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 119,159 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -1,749,580 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.31 | 0.25 | 0.42 | 0.31 | 0.24 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 10/02/20 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.30 | 16.07 | 15.00 | 9.63 |